Production of plasma proteins for therapeutic use /
Furkejuvvon:
| Eará dahkkit: | , , |
|---|---|
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Hoboken, N.J. :
John Wiley & Sons,
[2013]
|
| Fáttát: | |
| Liŋkkat: | https://biblioteca.ues.edu.sv/acceso/elibro/?url=https%3A%2F%2Felibro.net%2Fereader%2Fbiblioues/183749 Čájet áššehaslávttas |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- section 1. Introduction to plasma fractionation
- section 2. Plasma proteins for therapeutic use
- section 3. Pathogen safety of plasma products
- section 4. The pharmaceutical environment applied to plasma fractionation
- section 5. The market for plasma products and the economics of fractionation.